{"id":23576,"date":"2022-08-25T00:00:00","date_gmt":"2022-08-25T05:00:00","guid":{"rendered":"https:\/\/myeloma.ca\/2022\/08\/25\/le-vaccin-de-rappel-evusheld-ameliore-la-protection-des-patients-atteints-de-cancers-du-sang\/"},"modified":"2022-08-25T00:00:00","modified_gmt":"2022-08-25T05:00:00","slug":"le-vaccin-de-rappel-evusheld-ameliore-la-protection-des-patients-atteints-de-cancers-du-sang","status":"publish","type":"post","link":"https:\/\/myeloma.ca\/fr\/2022\/08\/25\/le-vaccin-de-rappel-evusheld-ameliore-la-protection-des-patients-atteints-de-cancers-du-sang\/","title":{"rendered":"Le vaccin de rappel Evusheld am\u00e9liore la protection des patients atteints de cancers du sang"},"content":{"rendered":"<p>A third dose of a COVID-19 vaccine can prompt seroconversion in patients with hematologic malignancies who failed to seroconvert after 2 doses, according to a study published in&nbsp;<em>Cancer<\/em>.<\/p>\n<p><strong><a href=\"https:\/\/www.hematologyadvisor.com\/home\/topics\/general-hematology\/blood-cancers-covid-19-vaccine-booster-evusheld-improve-protection\/?utm_source=newsletter&amp;utm_medium=email&amp;utm_campaign=NWLTR_HEM_UPDT_080222_RM&amp;hmEmail=t4mjb5pDq%2FT4EMHH1f6XPf%2FulL3aOOCE&amp;sha256email=f8197e3c3fe7c7a089d6a639a92231583494d8f5d9f107f3c8deff7a0952d05a&amp;hmSubId=&amp;NID=\" target=\"_blank\" rel=\"noopener\">Lire la suite ici<\/a><\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A third dose of a COVID-19 vaccine can prompt seroconversion in patients with hematologic malignancies who failed to seroconvert after 2 doses, according to a study published in&nbsp;Cancer. Lire la suite ici.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[72],"tags":[],"class_list":["post-23576","post","type-post","status-publish","format-standard","hentry","category-actualites-et-nouvelles-au-sujet-de-la-covid-19"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/comments?post=23576"}],"version-history":[{"count":0,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/posts\/23576\/revisions"}],"wp:attachment":[{"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/media?parent=23576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/categories?post=23576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myeloma.ca\/fr\/wp-json\/wp\/v2\/tags?post=23576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}